Abstract
Given the increasing prevalence of obesity in the United States, we sought to determine the effect of maternal obesity on the incidence of fetal prematurity morbidities, in those who receive antenatal corticosteroids. This could provide insight to whether a weight-based dose of antenatal corticosteroid should be pursued to improve clinical outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
